1 Comment
User's avatar
⭠ Return to thread
Michael Buratovich, Ph.D's avatar

The SGLT2 inhibitors are remarkable drugs for getting patients’ blood sugars down, but the raging UTIs and renal stones are a problem for some people. I have friends who benefitted from empaglaflozin, but had to get off it after a Candida glabrata infection ravaged her urogenital tract. It’s about trade offs and for this friend, the constant kidney stones and mycotic UTIs were too much to bear.

Expand full comment